Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National BioService (NBS) is a leading Russian contract research organization and biobank that provides high-quality human biospecimens and associated laboratory services to the global life sciences industry. Founded in 2014, the company specializes in the procurement of ethically sourced tissues, blood, and other biological materials across a broad range of therapeutic areas, including oncology and infectious diseases. NBS offers integrated solutions such as histology, immunohistochemistry, and molecular profiling to support drug discovery and biomarker validation. With a robust network of clinical partner sites, the company ensures rigorous quality control and compliance with international biobanking standards. Their services are designed to accelerate the development of personalized medicine and innovative diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National BioService.